Skip to main content
SpringerLink
Log in

Contemporary treatment of Western and Chinese medicine for cardiac syndrome X

  • Review
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Clinical reports on cardiac syndrome X (CSX) have been increasing in recent years. In general, CSX does not increase the cardiovascular mortality, but it can affect the patient’s quality of life (QOL) and increase the incidence rates of cardiovascular and cerebrovascular events. Although a variety of drugs and therapies have been utilized in the clinical treatment, the management of CSX still represents a major challenge due to its unclear pathogenesis. It is necessary to explore more effective treatment programs. Many attempts have been made on trials of the Chinese medicine (CM) treatment for CSX and proved that CM has a certain advantage in efficacy to improve clinical symptoms and QOL. CM may provide a new approach for the effective treatment of CSX.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Likoff W, Seagal BL, Kasparin H. Paradox of normal elective coronary arteriogram in patients considered to have unmistakable coronary hert disease. N Eng J Med 1967;276:1063–1066.

    Article  CAS  Google Scholar 

  2. Kemp HG. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1976;32:375–376.

    Google Scholar 

  3. Cannon RO, Epstein SE. “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988;61:1338–1343.

    Article  PubMed  Google Scholar 

  4. Kaski JC, ed. Chest pain with normal coronary angiograms: pathogenesis, diagnosis and management. London, UK: Kluwer Academic Publishers; 1999:1–12.

    Google Scholar 

  5. Shmilovich H, Deutsch V, Roth A, Miller H, Keren G, George J. Circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 2007;93:1071–1076.

    Article  PubMed  Google Scholar 

  6. Huang PH, Chen YH, Chen YL, Wu TC, Chen JW, Lin SJ. Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 2007;93:1064–1070.

    Article  PubMed  CAS  Google Scholar 

  7. Johnson BD, Shaw LJ, Pepine CJ, Reis SE, Kelsey SF, Sopko G, et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: Results from the NIH-NHLBI-sponsored Women’s Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J 2006;27:1408–1415.

    Article  PubMed  Google Scholar 

  8. Lanza GA, Manzoli A, Bia E, Crea F, Maseri A. Acute effects of nitrates on exercise testing in patients with syndrome X. Clinical and pathophysiological implications. Circulation 1994;90:2695–2700.

    PubMed  CAS  Google Scholar 

  9. Radice M, Giudici V, Pusineri E, Breghi L, Nicoli T, Peci P, et al. Different effects of acute administration of aminophylline and nitroglycerin on exercise capacity in patients with syndrome X. Am J Cardiol 1996;78:88–92.

    Article  PubMed  CAS  Google Scholar 

  10. Kaski JC, Aldama G, Cosín-Sales J. Cardiac syndrome X: diagnosis, pathogenesis and management. Am J Cardiovasc Drugs 2004;4:179–194.

    Article  PubMed  Google Scholar 

  11. Bao ZY, Mao JL. Diagnosis and therapy of cardiac syndrome X. Adv Cardiovasc Dis (Chin) 2006;27:296–298.

    Google Scholar 

  12. Lanza GA, Colonna G, Pasceri V, Maseri A. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol 1999;84:854–856.

    Article  PubMed  CAS  Google Scholar 

  13. Sen N, Tavil Y, Erdamar H, Yazici HU, Cakir E, Akgül EO, et al. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X. Anadolu Kardiyol Derg 2009;9:371–379.

    PubMed  Google Scholar 

  14. Erdamar H, Sen N, Tavil Y, Yazici HU, Turfan M, Poyraz F, et al. The effect of nebivolol treatment on oxidative stress and antioxidant status in patients with cardiac syndrome-X. Coron Artery Dis 2009;20:238–244.

    Article  PubMed  Google Scholar 

  15. Kayikcioglu M, Payzin S, Yavuzgil O, Kultursay H, Can LH, Soydan I. Benefits of statin treatment in cardiac syndrome-X. Eur Heart J 2003;24:1999–2005.

    Article  PubMed  CAS  Google Scholar 

  16. Fábián E, Varga A. Effect of simvastatin therapy on endothelial function of hypercholesteremic patients with syndrome X. Orv Hetil 2002;143:2067–2071.

    PubMed  Google Scholar 

  17. Fábián E, Varga A, Picano E, Vajo Z, Rónaszéki A, Csanády M. Effect of simvastatin on endothelial function in cardiac syndrome X patients. Am J Cardiol 2004;94:652–655.

    Article  PubMed  Google Scholar 

  18. Arroyo-Espliguero R, Kaski J. Microvascular dysfunction in cardiac syndrome X: the role of inflammation. Can Med Assoc J 2006;174:1833.

    Article  Google Scholar 

  19. Pizzi C, Manfrini O, Fontana F, Bugiardini R. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methy-lglutaryl coenzyme A reductase in cardiac syndrome X. Circulation 2004;109:53–58.

    Article  PubMed  CAS  Google Scholar 

  20. Maseri A. National Heart, Lung and Blood Institute, American College of Cardiology Foundation. Women’s Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2–4, 2002: perspective: new frontiers in detection of ischemic heart disease in women. Circulation 2004;109:e62–e63.

    Article  PubMed  Google Scholar 

  21. Rosano GM, Peters NS, Lefroy D, Lindsay DC, Sarrel PM, Collins P, et al. 17-beta-estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 1996;28:1500–1505.

    Article  PubMed  CAS  Google Scholar 

  22. Assali AR, Jabara Z, Shafer Z, Solodky A, Herz I, Sclarovsky E, et al. Insulin resistance is increased by transdermal estrogen therapy in postmenopausal women with cardiac syndrome X. Cardiology 2001;95:31–34.

    Article  PubMed  CAS  Google Scholar 

  23. Yeşildağ O, Yazici M, Yilmaz O, Uçar R, Sağkan O. The effect of aminophylline infusion on the exercise capacity in patients with syndrome X. Acta Cardiol 1999;54:335–337.

    PubMed  Google Scholar 

  24. Elliott PM, Krzyzowska-Dickinson K, Calvino R, Hann C, Kaski JC. Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X). Heart 1997;77:523–526.

    PubMed  CAS  Google Scholar 

  25. Deng HQ. Pathogenesis and treatment of cardiac syndrome X. South China J Cardiovasc Dis (Chin) 2008;14:390–391.

    Google Scholar 

  26. Lanza GA. Cardiac syndrome X: a critical overview and future perspectives. Heart 2007;93:159–166.

    Article  PubMed  CAS  Google Scholar 

  27. Sgueglia GA, Sestito A. Spinal cord stimulation: a new form of pain modulatory treatment in cardiac syndrome X. Am J Med 2007;120:e17.

    Article  PubMed  Google Scholar 

  28. Sgueglia GA, Sestito A, Spinelli A, Cioni B, Infusino F, Papacci F, et al. Long-term follow-up of patients with cardiac syndrome X treated by spinal cord stimulation. Heart 2007;93:591–597.

    Article  PubMed  Google Scholar 

  29. Sestito A, Lanza GA, Le Pera D, De Armas L, Sgueglia GA, Infusino F, et al. Spinal cord stimulation normalizes abnormal cortical pain processing in patients with cardiac syndrome X. Pain 2008;139:82–89.

    Article  PubMed  Google Scholar 

  30. Spinelli A, Lanza GA, Calcagni ML, Sestito A, Sgueglia GA, Monaco AD, et al. Effect of spinal cord stimulation on cardiac adrenergic nerve function in patients with cardiac syndrome X. J Nucl Cardiol 2008;15:804–810.

    PubMed  Google Scholar 

  31. Kisely S, Campbell LA, Skerritt P. Psychological interventions for symptomatic management of non-specific chest pain with normal coronary anatomy. Cochrane Database Syst Rev 2005; (1):CD004101.

    PubMed  Google Scholar 

  32. Tyni-Lenne R, Stryjan S, Eriksson B, Berglund M, Sylven C. Beneficial therapeutic effects of physical training and relaxation therapy in women with coronary syndrome X. Physiother Res Int 2002;7:35–43.

    Article  PubMed  Google Scholar 

  33. Kronhaus KD, Lawson WE. Enhanced external counterpulsation is an effective treatment for syndrome X. Int J Cardiol 2009;135:256–257.

    Article  PubMed  Google Scholar 

  34. Zhang MZ, Li XM. Syndrome differentiation and treatment of traditional Chinese medicine on microvascular angina. J Pract Med (Chin) 2001;17:177.

    Google Scholar 

  35. Xu LJ, Wang WY. Effects of quickening the blood and transforming stasis method on blood endothelin-1 level and endothelium-dependent vasodilatated function in patients with syndrom X. Chin Tradit Patent Med (Chin) 2002;24:519–521.

    Google Scholar 

  36. Lin N. Treatment of 11 cases with syndrome X by the method of invigorating qi and warming yangqi. J Pract Tradit Chin Intern Med (Chin) 2007;21 (7):68–69.

    Google Scholar 

  37. Zhang XY. Clinical experience of treatment for 48 patients with cardiac syndrome X by soothing liver and regulating qi. J Emerg Tradit Chin Med (Chin) 2008;17:1608–1609.

    Google Scholar 

  38. Wu HL, Hu LN. Therapeutic observation on the method of regulating the spleen to protect the heart in treating myocardial microvascular lesion. Henan Tradit Chin Med (Chin) 2009;29 (1):45–46.

    Google Scholar 

  39. Mao JY, Zhang ZP, Wang HH, Wang Q, Wang HL, Zhang Y, et al. Clinical analysis of 12 patients with cardiac syndrome X. J Emerg Tradit Chin Med (Chin) 2005;14:368–369.

    Google Scholar 

  40. Mao JY, Wang HH, Ge YB, Wang Q, Zhang QM, Chang YP, et al. Analysis on the characteristics of Chinese medicine syndrome in 51 patients with cardiac syndrome X. J Tradit Chin Med (Chin) 2007;48:1111–1112.

    Google Scholar 

  41. Mao JY, Ge YB, Wang HH, Wang Q, Zhang Y, Yu DL, et al. Summary of 32 patients with cardiac syndrome X treated by TCM therapy of regulating qi relieving chest stuffiness and promoting blood circulation. Chin J Integr Med (Chin) 2007;13:17–21.

    Article  Google Scholar 

  42. Wang XL, Mao JY, Wang HH, Yu KL, Wang Q, Zhang Y, et al. Clinical study on qi-regulating, chest-relaxing and blood-activating therapy for cardiac syndrome X. Shanghai J Tradit Chin Med (Chin) 2009;43:33–35.

    Google Scholar 

  43. Zhu XH, Jia YP. Clinical observation of decoction for removing blood stasis in the treatment of 30 cases of X-syndrome. J Henan Coll Tradit Chin Med (Chin) 2003;18 (2):59.

    Google Scholar 

  44. Zhang XH, Song QF. Taohong Siwu Decoction for the treatment of 20 patients with syndrome X. J Emerg Tradit Chin Med (Chin) 2002;11:137.

    Google Scholar 

  45. Zhao XD. Treatment of 38 patients with cardiac syndrome X by classic formulae. Henan Tradit Chin Med (Chin) 2003;23:10.

    Google Scholar 

  46. Liu H, Hu YC. The effect of Tongxinluo on the vascular endothelial function in patients with syndrome X. J Diffcult Complic Cases (Chin) 2003;4:218.

    Google Scholar 

  47. Bi XP, Cai XJ, Wei F. Clinical effect observation of Tongxinluo Capsule in treating patients with cardiac syndrome X. Hebei Med J (Chin) 2005;27:587.

    Google Scholar 

  48. Feng ZB, Li CM, Cheng RN, Yuan B. The clinical study of cardiac syndrome x treated with Tongxinluo Capsule. J Bethune Milit Med Coll (Chin) 2005;3:25–26.

    Google Scholar 

  49. Li SY, Tang Q. Clinical effect observation of Tongxinluo Capsule combined with Western medicine treatment in 36 cases with cardiac syndrome X. Yunnan J Tradit Chin Med Mater Med (Chin) 2009;30 (11):15–16.

    Google Scholar 

  50. Wang LW, Wang XB, Hu YS, Gao CR. Research on Xuefu Zhuyu Capsules for the treatment of cardiac syndrome X. Beijing J Tradit Chin Med (Chin) 2003;22 (3):65.

    Google Scholar 

  51. Li B, Mao L, Chen RY. Efficacy of Heart-protecting Musk Pill on patients with cardiac syndrome X. Chin J Integr Med Cardio-/Cereb Dis (Chin) 2009;7 (1):88–89.

    Google Scholar 

  52. Niu TF, Li J, Qi HX, Geng Q, Sun XH. Xinxuean Granular infusion for the treatment of 30 cases with cardiac syndrome X. Chin J Integr Med Cardio-/Cereb Dis (Chin) 2008;6:1025–1026.

    Google Scholar 

  53. Li JJ, Wang Y, Nie SP, Li Q, Li YS, Huang Y, et al. Xuezhikang, an extract of cholestin, decreases plasma inflammatory markers and endothelin-1, improve exercise-induced ischemia and subjective feelings in patients with cardiac syndrome X. Int J Cardiol (Chin) 2007;122:82–84.

    Article  Google Scholar 

  54. Zhang YL, Liu BX. The clinical study on 40 patients with CSX by the integrative treatment of Western and traditional Chinese medicine. Jiangsu J Tradit Chin Med (Chin) 2010;42 (8):31–32.

    Google Scholar 

  55. Ji YM, Ren BJ. The clinical study on the efficacy of Shuxuetong Injection for CSX. Chin J Integr Med Cardio-/Cereb Dis (Chin) 2009;7:1147–1148.

    Google Scholar 

  56. Wu LH, Sun JL, Wang CY. The clinical study on Shuxuetong Injection for CSX. Chin J Integr Med Cardio-/Cerebr Dis (Chin) 2010;8:652–653.

    Google Scholar 

  57. Larsen W, Mandleco B. Chest pain with angiographic clear coronary arteries: A provider’s approach to cardiac syndrome X. J Am Acad Nurse Pract 2009;21:371–376.

    Article  PubMed  Google Scholar 

  58. Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim HW, Scott KN, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National. Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 2004;109:2993–2999.

    Article  PubMed  Google Scholar 

  59. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002;106:653–658.

    Article  PubMed  Google Scholar 

  60. Wu, YL. The related research and treatment of collaterals disease and vascular disease. J Tradit Chin Med (Chin) 2006;47:163–165.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China

    Ying-fei Bi  (毕颖斐)

  2. Cardiovascular Department of the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China

    Jing-yuan Mao  (毛静远), Xian-liang Wang  (王贤良), Heng-he Wang  (王恒和) & Yong-bin Ge  (葛永彬)

  3. Cardiovascular Department of Guang’anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053, China

    Zhen-peng Zhang  (张振鹏)

Authors
  1. Ying-fei Bi  (毕颖斐)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jing-yuan Mao  (毛静远)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xian-liang Wang  (王贤良)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heng-he Wang  (王恒和)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yong-bin Ge  (葛永彬)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhen-peng Zhang  (张振鹏)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jing-yuan Mao  (毛静远).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bi, Yf., Mao, Jy., Wang, Xl. et al. Contemporary treatment of Western and Chinese medicine for cardiac syndrome X. Chin. J. Integr. Med. 17, 314–320 (2011). https://doi.org/10.1007/s11655-011-0714-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-011-0714-2

Keywords

Search

Navigation